Forbion — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
Exosome DiagnosticsJun 2015SEC filingmedium confidence
BiotechHealthtechCambridge, US
James McCullough(Executive Officer, Director)William Kelly(Chief Financial Officer and Secretary of Issuer)Thomas McLain(Chief Executive Officer and Director of Issuer)Sara Barrington(Executive Officer)
BoardJoseph Boystak(Director)
Board seatGeert-Jan Mulder· per SEC Form D · $2.2M raise · filed Jul 2015
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.